Cargando…
IFN‐γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease
Cell‐based therapy for the treatment of inflammatory disorders has focused on the application of mesenchymal stromal cells (MSCs) and multipotent adult progenitor cells (MAPCs). Despite the recent positive findings in industry‐sponsored clinical trials of MSCs and MAPCs for graft vs host disease (Gv...
Autores principales: | Carty, Fiona, Dunbar, Hazel, Hawthorne, Ian J., Ting, Anthony E., Stubblefield, Samantha R., Van't Hof, Wouter, English, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550699/ https://www.ncbi.nlm.nih.gov/pubmed/34397170 http://dx.doi.org/10.1002/sctm.21-0008 |
Ejemplares similares
-
Human multipotent adult progenitor cells effectively reduce graft‐vs‐host disease while preserving graft‐vs‐leukemia activity
por: Metheny, Leland, et al.
Publicado: (2021) -
Capillary‐resident EphA7(+) pericytes are multipotent cells with anti‐ischemic effects through capillary formation
por: Yoshida, Yuri, et al.
Publicado: (2019) -
Neural crest‐derived mesenchymal progenitor cells enhance cranial allograft integration
por: Glaeser, Juliane D., et al.
Publicado: (2021) -
Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure
por: Agarwal, Udit, et al.
Publicado: (2016) -
Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit
por: Hocine, Hocine Rachid, et al.
Publicado: (2019)